These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9295513)

  • 1. [Venous protection of acute leukemia treatment with amsacrine].
    Ma XJ; Xiang YM; Hong J
    Zhonghua Hu Li Za Zhi; 1996 Sep; 31(9):506-7. PubMed ID: 9295513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amsacrine (AMSA).
    Issell BF
    Cancer Treat Rev; 1980 Jun; 7(2):73-83. PubMed ID: 6931632
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of amsacrine, an investigational antineoplastic agent.
    Grove WR; Fortner CL; Wiernik PH
    Clin Pharm; 1982; 1(4):320-6. PubMed ID: 6764391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.
    Arlin ZA
    Cancer Treat Rep; 1983 Nov; 67(11):967-70. PubMed ID: 6357436
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated scientific data bases review on asulacrine and associated toxicity.
    Afzal A; Sarfraz M; Wu Z; Wang G; Sun J
    Crit Rev Oncol Hematol; 2016 Aug; 104():78-86. PubMed ID: 27321375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapeutic agents nocodazole and amsacrine cause meiotic delay and non-disjunction in spermatocytes of mice.
    Attia SM; Badary OA; Hamada FM; Hrabé de Angelis M; Adler ID
    Mutat Res; 2008 Mar; 651(1-2):105-13. PubMed ID: 18069049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).
    Von Hoff DD; Elson D; Polk G; Coltman C
    Cancer Treat Rep; 1980; 64(2-3):356-8. PubMed ID: 6931630
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of venous pain and phlebitis caused by epirubicin hydrochloride.
    Sugimoto M; Matsui M; Harada M; Yamauchi Y; Moriyama N; Andou K; Yamamoto M; Yamaoka H; Ono C; Ishikawa M; Kamo N; Ikeda T; Yamaoka K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):969-74. PubMed ID: 19542717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of AMSA in acute leukemia.
    Dupont JC; Garay GE; Scaghone C; Pavlovsky S; Woodley PV
    Cancer Treat Rep; 1982 Jul; 66(7):1596-7. PubMed ID: 7046933
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia.
    Tauro S; Shankaranarayana P; Nitu-Whalley IC; Duncan N; Begum G; Craig JI; Marcus RE; Craddock CF; Mahendra P
    Bone Marrow Transplant; 2003 Aug; 32(3):273-8. PubMed ID: 12858198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amsacrine evaluation.
    Van Mouwerik TJ; Caines PM; Ballentine R
    Drug Intell Clin Pharm; 1987 Apr; 21(4):330-4. PubMed ID: 3552546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of amsacrine-induced phlebitis with heparin.
    Case DC
    Clin Pharm; 1982; 1(6):490. PubMed ID: 6897887
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma.
    Blackhall FH; Ranson M; Radford JA; Hancock BW; Soukop M; McGown AT; Robbins A; Halbert G; Jayson GC;
    Br J Cancer; 2001 Feb; 84(4):465-9. PubMed ID: 11263437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer.
    Ikeda S; Douchi T; Nagata Y
    J Obstet Gynaecol Res; 2004 Dec; 30(6):427-9. PubMed ID: 15566456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to the complications of treatment for acute leukemia in the elderly.
    Gingerich J; Bow EJ
    Semin Hematol; 2006 Apr; 43(2):134-43. PubMed ID: 16616047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMSA toxicity in patients with abnormal liver function.
    Mahal PS; Legha SS; Valdivieso M; Luna M; Benjamin RS; Bodey GP
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1343-8. PubMed ID: 6896030
    [No Abstract]   [Full Text] [Related]  

  • 19. [Local obliterative hepatic endophlebitis and hepatosclerosis as a consequence of the therapy of infantile leukosis].
    Hill K; Jüngst BK
    Acta Hepatosplenol; 1969; 16(5):297-307. PubMed ID: 5358868
    [No Abstract]   [Full Text] [Related]  

  • 20. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
    Rickles FR; Falanga A; Montesinos P; Sanz MA; Brenner B; Barbui T
    Thromb Res; 2007; 120 Suppl 2():S99-106. PubMed ID: 18023721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.